Cargando…
Treatment, prognostic markers, and survival in thymic neuroendocrine tumors: A single center experience of 41 patients
Neuroendocrine tumors of the thymus (NETTs) are rare but aggressive, and lead to poor overall survival. This retrospective study was designed to analyze factors that correlate with the prognosis of patients with NETTs. From 1999 to 2015, 41 ongoing patients with NETTs were enrolled in this study. Th...
Autores principales: | Ma, Kefeng, Liu, Yi, Xue, Zhiqiang, Chu, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671811/ https://www.ncbi.nlm.nih.gov/pubmed/29068978 http://dx.doi.org/10.1097/MD.0000000000007842 |
Ejemplares similares
-
Long-term survival of a patient with an inoperable thymic neuroendocrine tumor stage IIIa under sole treatment with Viscum album extract: A CARE compliant clinical case report
por: Reynel, María, et al.
Publicado: (2020) -
Prognostic value of tumor size in thymic epithelial tumors: A systematic review and meta-analysis
por: Shao, Yifeng, et al.
Publicado: (2022) -
Long-Term Follow-Up and Prognostic Factors for Advanced Thymic Carcinoma
por: Wu, Jun-xin, et al.
Publicado: (2014) -
Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
por: Lin, Liang-Yu, et al.
Publicado: (2017) -
Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors: A SEER based study
por: Ge, Lina, et al.
Publicado: (2021)